Skip to content
The Nexus
BUSINESSJul 29 · 23:55 UTCBLOOMBERG

Teva CEO on Drug Pipeline, Direct Listing on NYSE

Teva Pharmaceuticals CEO Richard Francis discussed the company's positive Q2 earnings, the impact of changing Medicare rules on patients, and the new direct listing on the NYSE with Bloomberg reporter Romaine Bostick.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting

Teva CEO on Drug Pipeline, Direct Listing on NYSE · The Nexus